Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1896212 · FYE Dec 31 · Prices AT CLOSE 2026-08-28 (USD) Last $1.69 · Day −10.11% · Mkt cap $1M · 1Y −99.9% · Off 52W high −99.9% · Vol (1Y) 175.6% Price2023-09-25 → 2026-08-28 CDT close: $31,146,305 on 2023-09-25 to $2 on 2026-08-28. Split-adj closes · 240 of 730 · price returnⓘ At a glance | Short interest1.3% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)+0.00% | | Top-10 13F concentration100.0% | | Next report (est.)2026-11-11 |
SI 2026-08-14 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−99.5% | | 1Y−99.9% | | Since incept. (ann.)−99.7% |
Total return · from 2023-09-25ⓘ Risk | Ann. volatility (1Y)175.6% | | Ann. volatility (3Y)182.8% | | Sharpe (1Y)−3.38 | | Sharpe (3Y)−2.27 | | Max drawdown (1Y)−99.9% | | Max drawdown (3Y)−100.0% | | Beta (3Y vs SPY)4.50 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Tower Research Capital LLC (TRC) | 110 | $561 | 0.00% | −95.8% | | MORGAN STANLEY | 2 | $10 | 0.00% | −81.8% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-12 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-12 | — | — | — | — | | 2026-03-31 | 2026-07-15 | — | — | — | — | | 2025-09-30 | 2025-11-13 | — | — | — | — | | 2025-06-30 | 2025-08-14 | — | — | — | — |
As-reported XBRL · next 2026-11-11 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
